JERSEY CITY, N.J., July 29, 2024 /PRNewswire/ -- InsightAce Analytic
Pvt. Ltd. announces the release of a market assessment report on
the "Global Prescription Digital Therapeutics (PDT) Market
– (By Type (Medication Augmentation, Medication Replacement), By
Application (Children, Adults)), Trends, Industry Competition
Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the
Global Prescription Digital Therapeutics (PDT) Market is
valued at US$ 4.41 Bn in 2023, and it is expected to
reach US$ 21.18 Bn by 2031,
with a CAGR of 22.41% during the forecast period of
2024-2031.
Prescription Digital Therapeutics (PDT) represent a new category
of medical treatments that utilize software applications to deliver
therapeutic interventions under the supervision of healthcare
providers. Prescription digital drugs are created by combining
biology and technology. Artificial intelligence, various
algorithms, and virtual reality were used in the creation of these
therapeutic aids. Digital therapies, or prescription PDTs, are a
relatively new class of medications. PDTs function as direct
therapies for serious illnesses, just like traditional biologics or
prescription drugs do. The increased frequency of chronic illnesses
is a major factor impacting the growth rate of the prescription
digital therapeutics (PDT) market throughout the forecast
period.
Download Free Demo Report, Excel Pivot and ToC:
https://www.insightaceanalytic.com/request-sample/2604
List of Prominent Players in the Prescription Digital
Therapeutics (PDT) Market:
- Akili Interactive
- Better Therapeutics
- Pear Therapeutics
- ResMed
- Biofourmis
- Novartis
- Medtronic
- GAIA
- Solera Network
- BigHealth
- Voluntis
- Omada Health
- Click Therapeutics
- Natural cycles Nordic
- Happify
- Limbix Health
- NuvoAir
- Sensyne Health
- Xealth
- Other Prominent Players
Prescription Digital Therapeutics (PDT) Market Report
Scope:
Report
Attribute
|
Specifications
|
Market Size Value In
2023
|
USD 4.41 Bn
|
Revenue Forecast In
2031
|
USD 21.18 Bn
|
Growth Rate
CAGR
|
CAGR of 22.41% from
2024 to 2031
|
Quantitative
Units
|
Representation of
revenue in US$ Bn and CAGR from 2024 to 2031
|
Historic
Year
|
2019 to 2023
|
Forecast
Year
|
2024-2031
|
Report
Coverage
|
The forecast of
revenue, the position of the company, the competitive market
structure, growth prospects, and trends
|
Segments
Covered
|
By Type And
Application
|
Regional
Scope
|
North America; Europe;
Asia Pacific; Latin America; Middle East & Africa
|
Country
Scope
|
U.S.; Canada; U.K.;
Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain;
South East Asia; South Korea
|
Market Dynamics:
Drivers-
The market share of prescription digital therapeutics (PDT) is
expected to increase as more people utilize smartphones and
tablets. Moreover, the market for prescription digital therapeutics
(PDT) is expected to expand due to increasing government
initiatives aimed at enhancing healthcare services and the presence
of an aging population. In addition, the market's growth rate will
be accelerated by the ease of accessibility, patient comfort, and
the ability to affect behavioural change. Additionally, a sizable
pipeline of prospective products anticipated to be produced
throughout the projection period would present advantageous growth
prospects for the prescription digital therapeutics (PDT)
market.
Challenges:
Concerns about patient data privacy will hinder the market's
rate of expansion. Prescription digital therapeutics (PDT) market
challenges will come from developing economies' inadequate
healthcare infrastructure and shortage of qualified personnel.
Furthermore, during the projection period, the market's growth pace
will be further hindered by stringent government regulations and a
lack of knowledge regarding digital therapeutics in emerging
nations.
Regional Trends:
The North American prescription digital therapeutics (PDT)
market is anticipated to report a major market share in terms of
revenue owing to the improved quality of healthcare. Numerous
resources are available in the area, which makes it possible to
come up with new ideas for growing the company.
The region's dominance stems from technological advancement,
which enables it to innovate and implement the newest ideas
independently. Additionally, the region's numerous businesses and
increasingly sophisticated technologies boost this sector's growth.
Consequently, North America has
become a prominent actor on the international scene, establishing
the bar for effective, cutting-edge, and ecologically sustainable
platforms.
Curious About This Latest Version Of The Report? Enquiry
Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2604
Recent Developments:
- In Jan 2023, Pear Therapeutics
and BrightView Health extended their pilot program to offer
prescription digital therapies for the management of substance use
disorders. This initiative was created to offer eligible persons
who were experiencing substance use disorder (SUD) and opioid use
disorder (OUD) the opportunity to obtain reSET® and reSET-O®.
Segmentation of Prescription Digital Therapeutics (PDT)
Market-
By Type-
- Medication Augmentation
- Medication Replacement
By Application-
By Region-
North America-
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and
Africa
For More Customization @
https://www.insightaceanalytic.com/customisation/2604
Why should buy this report:
- To receive a comprehensive analysis of the prospects for global
Prescription Digital Therapeutics (PDT) market
- To receive industry overview and future trends of global
Prescription Digital Therapeutics (PDT) market
- To analyze the Prescription Digital Therapeutics (PDT) market
drivers and challenges
- To get information on the Prescription Digital Therapeutics
(PDT) market size value (US$ Mn) forecast till 2031
- Major Investments, Mergers & Acquisition in global
Prescription Digital Therapeutics (PDT) industry
Other Related Reports Published by InsightAce
Analytic:
Pharma 4.0 Market
Digital Pharmaceutical Supply Chain Management Market
Automated Drug Kiosk Market
Digital Therapeutics (DTx) For Mental Health Market
Digital Therapeutics & Medical Devices for Migraine
Market
About Us:
InsightAce Analytic is a market research and consulting firm
that enables clients to make strategic decisions. Our qualitative
and quantitative market intelligence solutions inform the need for
market and competitive intelligence to expand businesses. We help
clients gain competitive advantage by identifying untapped markets,
exploring new and competing technologies, segmenting potential
markets and repositioning products. Our expertise is in providing
syndicated and custom market intelligence reports with an in-depth
analysis with key market insights in a timely and cost-effective
manner.
Contact Us:
InsightAce Analytic PVT. LTD
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Follow us on LinkedIn:
https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Logo:
https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/prescription-digital-therapeutics-pdt-market-expected-to-grow-at-a-cagr-of-22-41-from-2024-to-2031--exclusive-report-by-insightace-analytic-pvt-ltd-302208494.html